EUROPEAN JOURNAL OF

PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

 ISSN (O) : 2394-3211

 ISSN (P) : 3051-2573

Impact Factor: 8.158

ICV - 79.57

Abstract

PHARMACOEPIDEMIOLOGICAL AND ECONOMIC EVALUATION OF DIABETES MELLITUS PATIENTS WITH CO-MORBIDITIES

*Dr. P. Narayana Swamy, Dr. R. Venkateswararao Rao, Dr. Karthik Muthusamy, S. Charishma, K. Satyadurga, K. Nani Babu and Prof. Rama Rao Nadendla

ABSTRACT

Introduction: Diabetes is one of the most common chronic disease, which occurs when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin it produces. This leads to an increased concentration of glucose in the blood (hyperglycemia). Aim and objectives: The aim of this study was to determine cost of illness and cost of utility in the study population and making recommendations to decrease the economic burden of the treatment by following the life style modifications. Methodology: It is a cross sectional pharmacoepidemiological study. Totally 132 diabetic patients both in-patients and out patients of medical and surgical departments in a secondary level referral hospital were included in this study which was conducted for a period of 6 months. All patients with diabetes type-II, continuing anti diabetic drugs (Metformin, Glibenclamide and Insulin,) for their diabetes management are included and patients who are diagnosed as Diabetic type-I and pregnancy and pediatric patients were excluded. Data was analyzed by Carlson comorbidities Index. Results: A total of 132 diabetic patients were included, in which male and famales were nearly equal in number. Based upon the comorbid conditions, it was found that the most of the subjects (69%) were suffering with diabetes along with hypertension and 9.9% are having comorbidity of hypertension & acute renal failure along with DM and treatment costs more economic burden to the patients. The average utility of drugs is more for the combination of Metformin+Glibenclamide+Insulin than metformin+glibenclamide. Conclusion: Finally we concluded that study place is a rural area and most of people are with poor knowledge and having lack of awareness on both disease and treatment. By applying Charlson Co morbidities index we found the patient’s economic status by which we found that many of the diabetic patients facing economic burden, especially daily wager are feeling much difficulty to face even therapy cost also. In co morbidities side, we noticed 55% of the study population are having diabetes with hypertension. Although all the patients were provided with education regarding their disease and drugs for improving their quality of life, but it has an influence on very few people.

Keywords: Diabetes, Epidemiology, Antidiabetics, Pharmacoeconomics.


[Full Text Article] [Download Certificate]

EJMPR Citation Report

  All Since 2021
 Citation  4339  2797
 h-index  23  20
 i10-index  109  52

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2026 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2026 issue has been successfully launched on 1 NOVEMBER 2026.

  • EJPMR: New Impact Factor 2026

    EJPMR Impact Factor has been Increased from 7.065 to 8.158, for Year 2026

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

BEST ARTICLE AWARDS

European Journal of Pharmaceutical and Medical Research is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Prof. Dr. Dhrubo Jyoti Sen
Download Article : Click Here

Google Scholar

Indian Science Publications

InfoBase Index (In Process)

SOCOLAR, China

Research Bible, Fuchu, Tokyo. JAPAN

International Society for Research activity (ISRA)

Scientific Indexing Services (SIS)

Polish Scholarly Bibliography

Global Impact Factor (GIF) (Under Process)

Universal Impact Factor

International Scientific Indexing (ISI), UAE

Index Copernicus

CAS (A Division of American Chemical Society) USA (Under Process)

Directory of Open Access Journal (DOAJ, Sweden, in process)

UDLedge Science Citation Index

CiteFactor

Directory Of Research Journal Indexing (DRJI)

Indian citation Index (ICI)

Journal Index (JI, Under Process)

Directory of abstract indexing for Journals (DAIJ)

Open Access Journals (Under Process)

Impact Factor Services For International Journals (IFSIJ)

Cosmos Impact Factor

Jour Informatics (Under Process)

Eurasian Scientific Journal Index (ESJI)

International Innovative Journal Impact Factor (IIJIF)

Science Library Index, Dubai, United Arab Emirates

Pubmed Database [NLM ID: 101669306] (Under Process)

IP Indexing (IP Value 2.40)

Web of Science Group (Under Process)

Directory of Research Journals Indexing

Scholar Article Journal Index (SAJI)

International Scientific Indexing ( ISI )

Scope Database

Academia

Doi-Digital Online Identifier

ISSN National Centre

Zenodo Indexing

International CODEN Service, USA